339 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B Downtrend
Article Searches
ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line http://www.zacks.com/stock/news/408323/resmeds-rmd-q3-earnings-beat-estimates-revenues-in-line?cid=CS-ZC-FT-408323 May 03, 2019 - ResMed (RMD) registers double-digit global revenue growth in Q3 on the back of solid sales from Software-as-a-Service businesses and new mask products plus devices.
ABBOTT LABORATORIES (ABT) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/02/abbott-laboratories-abt-q1-2019-earnings-call-tran.aspx?source=iedfolrf0000001 May 02, 2019 - ABT earnings call for the period ending March 31, 2019.
Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1 http://www.zacks.com/stock/news/407597/amedisys-amed-tops-earnings-and-revenue-estimates-in-q1?cid=CS-ZC-FT-407597 May 02, 2019 - At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.
ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan http://www.zacks.com/stock/news/407593/abiomed-abmd-q4-earnings-meet-estimates-sales-rise-in-japan?cid=CS-ZC-FT-407593 May 02, 2019 - ABIOMED's (ABMD) Q4 results gain from solid Impella show in Japan.
Hologic's (HOLX) Q2 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/407589/hologics-holx-q2-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-407589 May 02, 2019 - Hologic (HOLX) registers solid Q1year-over-year revenue growth in core businesses like Breast Health and Molecular Diagnostics.
CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up http://www.zacks.com/stock/news/406787/cvs-healths-cvs-q1-earnings-top-estimates-eps-view-up?cid=CS-ZC-FT-406787 May 01, 2019 - Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.
Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark http://www.zacks.com/stock/news/406770/tandems-tndm-q1-loss-wider-than-expected-sales-top-mark?cid=CS-ZC-FT-406770 May 01, 2019 - Tandem's (TNDM) introduction of t:slim X2 with Basal-IQ technology, ramped-up supply capacity along with its global launch, substantially drive its top line in Q1.
Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y http://www.zacks.com/stock/news/405943/chemed-che-q1-earnings-miss-estimates-revenues-grow-y-y?cid=CS-ZC-FT-405943 Apr 30, 2019 - Despite several downsides, Chemed (CHE) witnesses solid revenue growth across key subsidiaries - VITAS and Roto-Rooter.
Top Ranked Income Stocks to Buy for April 29th http://www.zacks.com/commentary/405059/top-ranked-income-stocks-to-buy-for-april-29th?cid=CS-ZC-FT-405059 Apr 29, 2019 - Top Ranked Income Stocks to Buy for April 29th
20 High-Growth Stocks For The Next 20 Years https://www.fool.com/investing/2019/04/29/20-high-growth-stocks-for-the-next-20-years.aspx?source=iedfolrf0000001 Apr 29, 2019 - If you're hunting for top growth stocks to add to long-term portfolios, you ought to consider these fast-growing companies.

Pages: 1234567...34

<Page 2>